Shivan Seratva's questions to Mirion Technologies Inc (MIR) leadership • Q4 2024
Question
Shivan Seratva, on behalf of R.W. Baird, asked for color on the drivers behind the 2025 adjusted EBITDA margin expansion and inquired about any early traction from the Siemens Healthineers partnership.
Answer
CFO Brian Schopfer attributed the guided margin expansion to a mix of operating leverage, procurement savings, and efficiencies from facility consolidations, with growth expected across both segments. CEO Tom Logan described the Siemens Healthineers relationship as being in its early days, with Mirion's software now in the Siemens price book. He clarified that the 2025 outlook assumes almost no incremental revenue from the deal, meaning any significant commercial traction would represent upside to the current guidance.